Table 1.
demographic and clinical characteristics of 244 postmenopausal patients screened for endometrial cancer from February 2016 to December 2019 at Gyeongsang National University Changwon Hospital in South Korea
| Characteristics | Group A (n=51) | Group B (n=193) | p-value |
|---|---|---|---|
| Age (year) | 61.6 ± 9.7 | 56.6 ± 6.3 | 0.001* |
| Parity | 2.4 ± 1.0 | 2.3 ± 0.7 | 0.564* |
| Weight (Kg) | 58.8 ± 8.8 | 59.8 ± 8.0 | 0.443* |
| BMI (Kg/m2) | 24.2 ± 3.5 | 24.1 ± 3.1 | 0.784* |
| Menopausal age | 50.3 ± 4.0 | 50.7 ± 2.7 | 0.436* |
| Duration of menopause | 11.3 ± 11.1 | 5.9 ± 7.1 | 0.002* |
| Underlying condition | |||
| Hypertension | 27 (52.9) | 35 (18.1) | 0.000† |
| Diabetes | 6 (11.8) | 20 (10.4) | 0.773† |
| Thyroid disease | 2 (3.9) | 15 (7.8) | 0.537ǂ |
| MHT | 0 (0) | 10 (5.2) | 0.127ǂ |
| Tamoxifen use | 5 (9.8) | 8 (4.1) | 0.153ǂ |
| Hx of endometrial hyperplasia | 10 (19.6) | 11 (5.7) | 0.004ǂ |
| Operation history | |||
| Gastric cancer | 3 (5.9) | 4 (2.1) | 0.161ǂ |
| Breast cancer | 7 (13.7) | 10 (5.2) | 0.057ǂ |
| Thyroid cancer | 0 (0) | 8 (4.1) | 0.210ǂ |
| Symptom | |||
| Vaginal bleeding | 37 (72.5) | 106 (54.9) | 0.023† |
| Abdominal pain | 4 (7.8) | 9 (4.7) | 0.480ǂ |
| Vaginal discharge | 7 (13.7) | 13 (6.7) | 0.146ǂ |
| No symptom | 3 (5.9) | 65 (33.7) | 0.000† |
Group A included patients with endometrial cancer; group B included patients with non-malignant lesions; values are presented as mean ± standard deviation or number (%); *p-value obtained by student t-test; †p-value obtained by Chi-square test; ǂp-value obtained by Fisher's exact test; p-value of less than 0.05 was considered to be significant; MHT: menopause hormonal therapy; Hx: history